{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:09:49Z","timestamp":1778623789701,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["MUHLEBA19A0"],"award-info":[{"award-number":["MUHLEBA19A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcf.2023.10.015","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:37:21Z","timestamp":1699616241000},"page":"300-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0982-4386","authenticated-orcid":false,"given":"Kushal S.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Saiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"LiPuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-9738","authenticated-orcid":false,"given":"Michael R.","family":"Kosorok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-1598","authenticated-orcid":false,"given":"Marianne S.","family":"Muhlebach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcf.2023.10.015_bib0001","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/ers.10.42","article-title":"Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis","volume":"4","author":"Clifton","year":"2010","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Infection prevention and control guideline for cystic fibrosis: 2013 update","volume":"35","author":"Saiman","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.jcf.2023.10.015_bib0003","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/ice.2018.72","article-title":"surveying cystic fibrosis care centers to assess adoption of infection prevention and control recommendations","volume":"39","author":"Saiman","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.jcf.2023.10.015_bib0004","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1784","article-title":"Clinical practice guidelines from the cystic fibrosis foundation for preschoolers with cystic fibrosis","volume":"137","author":"Lahiri","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0005","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1378\/chest.125.1_suppl.1S","article-title":"Cystic fibrosis adult care: consensus conference report","volume":"125","author":"Yankaskas","year":"2004","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.123.1.20","article-title":"Factors influencing outcomes in cystic fibrosis: a center-based analysis","volume":"123","author":"Johnson","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jcf.2023.10.015_bib0007","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ppul.23147","article-title":"Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site","volume":"50","author":"Schechter","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0008","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1136\/bmjqs-2013-002363","article-title":"Improving chronic care delivery and outcomes: the impact of the cystic fibrosis Care Center Network","volume":"23","author":"Mogayzel","year":"2014","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0009","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1136\/bmjqs-2013-002369","article-title":"Key findings of the US cystic fibrosis foundation's clinical practice benchmarking project","volume":"23","author":"Boyle","year":"2014","journal-title":"BMJ Qual Saf"},{"issue":"2","key":"10.1016\/j.jcf.2023.10.015_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ppul.23635","article-title":"Implementation of cystic fibrosis clinical pathways improved physician adherence to care guidelines","volume":"52","author":"Singh","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2023.10.015_bib0011","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/MOP.0b013e328339550e","article-title":"Improving the quality of care for patients with cystic fibrosis","volume":"22","author":"Schechter","year":"2010","journal-title":"Curr Opin Pediatr"},{"issue":"9","key":"10.1016\/j.jcf.2023.10.015_bib0012","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ppul.20876","article-title":"Barriers to adherence to cystic fibrosis infection control guidelines","volume":"43","author":"Garber","year":"2008","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2023.10.015_bib0013","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jcf.2021.07.009","article-title":"Barriers implementing infection prevention and control experienced by healthcare workers, people with CF and parents","volume":"21","author":"Saiman","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.10.015_bib0014","article-title":"Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016","author":"Muhlebach","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2015-207983","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.jcf.2023.10.015_bib0016","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2023.10.015_bib0017","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr"},{"issue":"10","key":"10.1016\/j.jcf.2023.10.015_bib0018","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcf.2023.10.015_bib0019","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.jcf.2023.10.015_bib0020","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jcf.2023.10.015_bib0021","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jcf.2017.10.005","article-title":"Do cystic fibrosis centres with the lowest FEV(1) still use the least amount of intravenous antibiotics? A registry-based comparison of intravenous antibiotic use among adult CF centres in the UK","volume":"17","author":"Hoo","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2023.10.015_bib0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.NCQ.0000313759.33654.00","article-title":"Creating a culture of improvement: experience of a pediatric cystic fibrosis center","volume":"23","author":"Britton","year":"2008","journal-title":"J Nurs Care Qual"},{"issue":"5","key":"10.1016\/j.jcf.2023.10.015_bib0023","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1017\/S0950268815002411","article-title":"Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis","volume":"144","author":"Psoter","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"S2","key":"10.1016\/j.jcf.2023.10.015_bib0024","first-page":"124","article-title":"Regional and socioeconomic determinants of incident infections","volume":"54","author":"Muhlebach","year":"2019","journal-title":"Ped. Pulm."},{"issue":"9","key":"10.1016\/j.jcf.2023.10.015_bib0025","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ajic.2019.03.015","article-title":"Cystic fibrosis program characteristics associated with adoption of 2013 infection prevention and control recommendations","volume":"47","author":"Stoudemire","year":"2019","journal-title":"Am J Infect Control"},{"issue":"5","key":"10.1016\/j.jcf.2023.10.015_bib0026","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcf.2009.05.004","article-title":"Implementation of European standards of care for cystic fibrosis - provision of care","volume":"8","author":"Elborn","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2023.10.015_bib0027","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcf.2009.03.001","article-title":"Implementation of European standards of care for cystic fibrosis\u2013control and treatment of infection","volume":"8","author":"Elborn","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2023.10.015_bib0028","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S1569-1993(11)60003-9","article-title":"The implementation of standards of care in Europe: state of the art","volume":"10","author":"Colombo","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0029","doi-asserted-by":"crossref","first-page":"i73","DOI":"10.1136\/bmjqs-2013-002315","article-title":"Improved patient safety through reduced airway infection rates in a paediatric cystic fibrosis programme after a quality improvement effort to enhance infection prevention and control measures","volume":"23","author":"Savant","year":"2014","journal-title":"BMJ Qual Saf"},{"issue":"3","key":"10.1016\/j.jcf.2023.10.015_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1651-2227.1989.tb11099.x","article-title":"Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients","volume":"78","author":"Hoiby","year":"1989","journal-title":"Acta Paediatr Scand"},{"issue":"1","key":"10.1016\/j.jcf.2023.10.015_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2006.02.021","article-title":"Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review","volume":"64","author":"Festini","year":"2006","journal-title":"J Hosp Infect"},{"issue":"2","key":"10.1016\/j.jcf.2023.10.015_bib0032","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2019.07.010","article-title":"The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: a CF patient registry study","volume":"19","author":"Franck Thompson","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2023.10.015_bib0033","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The cystic fibrosis foundation patient registry. Design and methods of a national observational disease registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:50Z","timestamp":1778620490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323016636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1569199323016636"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.10.015","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}